BackNeuroSense Therapeutics Ltd - Warrants (09/11/2026) Overview
NeuroSense Therapeutics Ltd - Warrants (09/11/2026)

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) PEG Ratio

Latest PEG ratio for NeuroSense Therapeutics Ltd - Warrants (09/11/2026): -1.73 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-1.73

PEG Ratio

-1.73

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

Average PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) (NRSNW) FAQ

As of the most recent data, NRSNW shows a PEG ratio of -1.73. That is above the sector sector average of -3.76. Scroll down for historical charts and peer comparison views.

The its sector sector average PEG ratio is about -3.76. NeuroSense Therapeutics Ltd - Warrants (09/11/2026) is at -1.73, which is higher that average. That is roughly 53.9% above the sector mean. Use the comparison chart on this page to see how NRSNW stacks up against individual peers as well.

Investors watch NRSNW's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s latest reading is -1.73. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently -1.73) with ownership activity and broader fundamentals.